New Market Opportunity Analysis and forecast to 2018 prepared by GlobalData highlights Visonac photodynamic therapy for acne as one of the anticipated new product launches that will drive the expansion within the acne market.

Heather Leach, Ph.D., GlobalData's Analyst covering Immunology, says: "The forthcoming market expansion can be attributed to the highly anticipated launches of AndroScience's ASC-J9 and Photocure's Visonac in 2017. The continued uptake and success of Galderma's Epiduo, with its label expansion into the pediatric population and launch of the Epiduo TAP program to improve patient compliance, will also prove a key driver behind the growth."

 Read more at:

http://healthcare.globaldata.com/media-center/press-releases/pharmaceuticals/novel-product-launches-to-reinvigorate-acne-treatment-market-by-2018-says-globaldata

distributed by